Cell Based Assay Services for Cytotoxicity, Potency, Bioactivity by PhD Scientists at 20+ Year, FDA-Inspected Lab

Cell-based assays measure what a compound or biologic does to living cells: viability, proliferation, death, signaling, function or potency. They answer questions a biochemical assay cannot, because permeability, efflux and real cellular context are part of the measurement. In drug development they carry discovery screens, mechanism of action packages, safety reads and the potency assays that release lots.

They are the bridge between a purified-target result and a living system. Discovery uses them to rank compounds in relevant biology; development uses them for mechanism, safety and immunogenicity readouts; and manufacturing depends on validated cell-based potency assays for lot release. Because the same living-system logic runs through all three, an assay built well at discovery can graduate through validation instead of being rebuilt.

A validated cell-based readout that reports relative potency against a reference standard, with system suitability, plate acceptance and assay windows that survive GxP scrutiny, because when the potency assay cannot pass validation, a finished lot cannot ship. We build for the validation window from day one: cell bank strategy, reference standard plan and acceptance criteria are set before the assay is optimized, not after it fails.

Yes. Where no commercial line carries your target in relevant biology, we build transient or stable models, qualify them, and bank them so the assay stays reproducible across years of lots and cohorts. Sponsors can also send an existing line with its history, and we qualify it into the assay rather than starting over.

When the regulator or the mechanism demands proof that antibodies block biological activity, not just binding. High-risk products, agonists, and therapeutics homologous to endogenous proteins usually need the cell-based format; a competitive ligand-binding NAb can serve lower-risk programs. We match the format to your mechanism and risk assessment and document the reasoning, since that choice gets asked about in review.

Yes, and it changes the economics. The assay that screens your candidates at the research tier can graduate into a validated potency method with its history intact: same cells, same readout logic, same scientists, more rigor. That continuity is exactly what a validation report wants to cite, and it is why work that starts here at discovery tends to stay through lot release.

Cell based assays use living cells to measure the biological activity or effect of a compound, such as a drug, a toxin, or a biomolecule. Different cell-based assays depend on cell type, assay format, detection method, and outcome of interest. Some common types of cell based assays are:

• Cell viability assays measure the number or percentage of live cells in a population after exposure to a compound. They can use various indicators of cell health, such as membrane integrity, metabolic activity, enzyme activity, or ATP content. Examples of cell viability assays are MTT, WST, LDH, and ATP assays.
• Cell proliferation assays measure cell division and growth rate or extent in response to a compound. They can use various cell proliferation markers, such as DNA synthesis, cell cycle progression, or cell number. Examples of cell proliferation assays are BrdU, EdU, CFSE, and Ki-67 assays.
• Cell death assays measure the occurrence or mode of cell death induced by a compound. They can use various indicators of cell death, such as DNA fragmentation, caspase activation, phosphatidylserine exposure, or mitochondrial membrane potential. Examples of cell death assays are TUNEL, Annexin V, JC-1, and Caspase-Glo assays.
• Cell signaling assays measure a compound’s activation or inhibition of cellular signaling pathways or networks. They can use various readouts of cell signaling, such as phosphorylation, transcription, or reporter gene expression. Examples of cell signaling assays are ELISA, Western blot, FACS, and luciferase assays.
• Cell function assays measure the functional behavior or performance of a cell or a cell population in response to a compound. They can use various cell function assays, such as cytokine secretion, cell migration, cell invasion, cell adhesion, or cell differentiation. Examples of cell function assays are ELISPOT, Transwell, Matrigel, and Alizarin Red assays.

The different types of assays in cell culture are methods that use cultured cells to measure diverse attributes of cell biology, such as cell viability, cell proliferation, cell death, cell signaling, cell function, cell differentiation, cell morphology, or cell interaction. Examples of assays in cell culture are MTT, BrdU, TUNEL, ELISA, Transwell, Matrigel, Alizarin Red, and co-culture assays.

Cell proliferation assays measure the rate or extent of cell growth and division to a compound, such as a drug, a toxin, or a biomolecule. Cell proliferation assays can provide information about the stimulatory or inhibitory effect of a compound on cell proliferation. Cell proliferation assays can also help to evaluate the cell cycle status, the cell number, or the cell density of a cell population.

An assay for cell viability is a method that measures the number or percentage of live, healthy cells in a sample. Cell viability assays determine the overall health of cells, optimize culture or experimental conditions, and measure cell survival following treatment, such as a drug screen.

Cell based screening assays use living cells to test many compounds for their potential biological activity or effect on a cell or a cell population. Cell based screening assays can measure various aspects of cell biology, such as cell viability, cell proliferation, cell death, cell signaling, cell function, cell differentiation, cell morphology, or cell interaction. Cell based screening assays differ from other screening methods, such as biochemical or biophysical assays, in that they provide a more relevant and realistic model of the cellular response to a compound in a physiological context.